Ainuovirine

艾诺韦林

Report date: 2025/05/28 15:18:06
NME

Base Information

Drug NameAinuovirine
Drug Alias NameAibangdeEinovirine艾邦德iBondACC007 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsReverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseReverse transcriptase
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2021/06/25
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKainos Medicine Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesKainos Medicine Inc
Active IndicationsHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeJ05AG
Related LinksN/A